Clinical Trials Update: Nov. 19, 2010
(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Read more on HealthDay via Yahoo! News
Phase 2 Study of Eculizumab (Soliris®) in Patients with aHUS Resistant to Plasma Therapy Met Primary and Secondary …
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced today that a Phase 2 clinical study investigating Soliris ® (eculizumab)...
